There is a widely discussed problem of publication bias in medical and health services research. Where quantitative effects form the basis of a publication a 'winner's curse' curse may apply. This phenomenon may occur as prospective authors of research papers compete by reporting 'more extreme and spectacular results' in order to increase the chances of their paper being accepted for publication. This paper examines this phenomenon using quantitative findings on income and price elasticities as reported in health economics research. We find robust statistical evidence that higher-impact journals preferentially report larger empirical estimates of these elasticities. That is, we find robust evidence of a winner's curse hypothesis contributing to the existence of publication bias found in both the income and the price elasticities of health care and drugs, as well as value of life research.
I. INTRODUCTION
The rapid growth of health policy research has led to the use of economics based concepts in policymaking, including the application of income and price elasticity estimates. More specifically, for three decades, economists have debated whether the income elasticity of health care demand suggests that health care is a luxury (Newhouse, 1977) with obvious consequences for public intervention in health care financing. 1 Existing studies show mixed results with some scholars suggesting a potential empirical bias (See Costa-Font et al, 2011) .
Similarly, many studies have been devoted to estimating the price elasticity for prescription drugs using survey, observational and experimental data, partly to inform copayment levels for these products, but there have been marked differences in these estimated elasticities (see Gemmill et al, 2007) . Such examples suggest that there might be an alternative explanation to the patterns of reported research results as found in health research. The purpose of this paper is to explore whether there is, in fact, a "winner's curse" in published health policy research.
Some researchers have suggested that the publication of medical research suffers from a phenomenon defined as 'winner's curse.' 2 More precisely they state that "The current system of publication in biomedical research provides a distorted view of the reality of scientific data that are generated in the laboratory and clinic. . . . (T)he more extreme, spectacular results (the largest treatment effects, the strongest associations, or the most unusually novel and exciting biological stories) may be preferentially published" (Young et al., 2008) .
The purpose of this paper is to test the 'winner's curse' hypothesis as it applies to specific aspects of health economics research and, in the process, to investigate the health care-income elasticity puzzle more deeply. Recently developed meta-regression analysis (MRA) methods that are able to identify and correct publication selection bias are applied to exisiting findings and suggest confirmation of a 'winner's curse' in two areas of health research: health care income elasticities and prescription drug price elasticities (Gemmill et al., 2007; Stanley, 2008; Moreno et al., 2009; Costa-Font et al., 2011) . That is, these methods allow investigation of potential publication bias in these two areas of health research and whether higher impact journals amplify this bias by reporting the largest effects.
Our findings have important implications for health care policy and financing.
Whether health care is a luxury or a necessity is more than a technical debate about the finer points of econometrics and its application. This health care-luxury issue may be misinterpreted to have important health policy implications. If health care were considered a luxury good, or so the argument goes, then demand will increase more rapidly than income, and richer countries should be expected to spend more than poorer countries per capita. Also, some might use such a 'luxury' status to suggest that public financing should play a subsidiary role. The use and abuse of such economic distinctions can be seen in the recent debate around the US health care reform (Glied, 2009; Phelps, 2010) . Furthermore, the price elasticity of prescription drugs is a fundamental parameter in the design of drug reimbursement and levels of copayment. The policy importance of this key elasticity is increasing as prescription medicines progressively represent a larger share of total health expenditures.
Although there is a sizable literature on price and expenditure elasticities of prescribed drugs, estimates vary greatly. Thus, it is critical to have a comprehensive and quantitative summary of this large literature, which disentangles potential biases and heterogeneity.
II. PUBLICATION SELECTION AND THE WINNER'S CURSE

Publication Selection
For a half-century, medical researchers, as well as some economists have expressed concerns about the detrimental effects of publication selection (Sterling, 1959; Tullock, 1959; Feige, 1975; Rosenthal, 1979; Lovell, 1983; Begg and Berlin, 1988; DeLong and Lang, 1992; Card and Krueger, 1995; Sterling, Rosenbaum and Weinkam, 1995; Copas, 1999) . Publication selection bias is widely acknowledged as a threat to scientific practice and statistical inference. When reported results are selected for statistical significance or for some 'positive'
finding, empirical phenomena can be manufactured, becoming mere artifacts of the publication selection process. For example, the efficacy of intravenous magnesium to treat myocardial infarction ('heart attack') and the adverse employment effect of raising the minimum wage are seen by many researchers as established facts; yet, these effects can be shown to be nothing more than publication selection bias (Egger and Smith, 1995; Higgins and Spiegelhalter, 2002; Doucouliagos and Stanley, 2009 ).
Publication selection is the preference for statistically significant or 'positive'
findings. In the social sciences, it may manifest itself through editors, reviewers, and researchers themselves having a preference for statistically significant findings. This practice has been colorfully called the 'file drawer' problem to describe the tendency for researchers to file away, and hence not publish or report, their insignificant results (Rosenthal, 1979) .
The real problem of publication selection is not its widespread existence, but rather the potentially large biases it imparts upon any summary of empirical findings, medical or economic. For example, the average reported value of a statistical life may be biased by a factor of five or more , and a similar exaggeration is found among the adverse employment effects of minimum wage raises (Doucouliagos and Stanley, 2009 ).
Or to use another health care example, the increased rate of smoking cessation caused by using nicotine replacement therapy (the patch) is likely to be exaggerated three fold (see below). Accommodating publication selection places the efficacy of nicotine replacement therapy in jeopardy. The spillover effects of such biases into the policy arena may thus have damaging effects.
A Winner's Curse of Research Publication
Recently, collaboration between medical researchers and economists offers an economic interpretation for the "file drawer" problem (Young et al., 2008) . That is, they give an economic explanation to the widely observed phenomenon of publication selection. Fierce competition among researchers for the scarce space in the top academic journals allows editors and reviewers to demand "more extreme, spectacular results." 3 Young et al. (2008) call this phenomenon the 'winner's curse' after the price anomaly where bidders pay an irrationally high price in a common value auction market in an effort to 'win.' This connection to the winner's curse is to view the bid as the size and importance of the reported research findings. As Johnson (2008) summarizes this phenomenon for the Economist, "(T)he winners could be the ones most likely to oversell themselves-to trumpet dramatic or important results that later turn out to be false." 4
Unfortunately, there is little to distinguish this 'winner's curse of research publication' (WCRP) from the long established and better-known "file drawer" problem of publication selection. However, if WCRP were correct, then the severity of publication bias should vary directly with the amount of competition for scarce journal space. In a publishing context, journal quality, which is widely though imperfectly, measured by impact factor, could serve as a proxy for the strength of the competition among researchers. In general, higher ranked journals attract a larger number of papers, accept a smaller proportion of them, and can thereby demand more significant, striking or novel results. Thus, we have a testable hypothesis that distinguishes WCRP from the more general phenomenon of publication selection, because general publication selection need not be correlated with journal impact factor. 5
To recap, the winner's curse implies that the magnitude of reported empirical effects will be positively associated with journal input factor, ceteris paribus, after more conventional publication selection bias is accommodated. We test this hypothesis explicitly in Section III using estimated aggregate income elasticities of health care and price elasticities for prescribed drugs. First, however, we review meta-analytic methods designed to identify and correct publication selection bias illustrating through using published data on the effect of antidepressant medications, nicotine replacement therapy, aggregate income elasticities for health care and prescription drug price elasticities.
Identifying and Correcting Publication Bias
By now, publication selection bias has been found in dozens of areas of economics research.
Examples include: Ashenfelter and Greenstone (2004) and for the value of life; Rose and Stanley (2005) for the common currency effect on trade; Mookerjee In medical research, where publication selection is widely acknowledged to be a severe problem, "the most commonly used method to detect publication bias is an informal examination of a funnel plot" (Sutton et al., 2000 (Sutton et al., , p.1574 . A 'funnel graph' is a scatter diagram of an estimate and its precision (1/SE i ). When there is no publication selection, this scatter diagram should resemble an inverted funnel, hence the name. A good example of this expected funnel symmetry is seen among the 73 randomized clinical trials (RCT) of antidepressants registered at the US Food and Drug Administration (FDA) (double-blind, placebo-controls Phase II and III). Medical researchers regard the FDA registry as the 'gold standard,' because all such clinical trials must, by law, be registered with the FDA. Figure 1 plots effect sizes (Glass's g) on the horizontal axis against the precision of these effect sizes (or 1/SE i ) on the vertical axis- (Turner et al., 2008) . Note how this graph, Figure 1 , resembles an inverted funnel, or perhaps a 'Christmas tree' in this example. Because these estimates' precisions are placed on the vertical axis, we expect the estimates to be widely dispersed at the bottom and more tightly packed, horizontally, at the top. However, it is symmetry or its absence (asymmetry) that truly matters. When there is no publication selection, we expect the funnel graph to be roughly symmetric, see the diamonds in Figure 1 . The results of the 73 clinical trials of antidepressants registered at the FDA are approximately symmetric; however, the fifty that are published are very skewed,
showing clear signs of being selected to be positive and statistically significant (Turner et al., 2008; Moreno et al., 2009b) .
Symmetry follows from the fact that each reported estimate will be randomly and symmetrically distributed around the 'true effect,' assuming for the moment that heterogeneity is not coincidentally related to SE. Furthermore, when researchers report tvalues, they are assuming that their estimates are independent of their standard errors;
otherwise, the t-test would be invalid. Of course, there is likely to be more than one 'true effect' (i.e., heterogeneity), which is routinely modeled by multiple meta-regression analysis.
Publication selection can be easily placed into this larger, multivariate context of heterogeneity and other types of bias -see Tables 3-5 below. Before returning to these important complexities, publication selection needs to be more fully discussed.
Consider a more typical funnel graph, Figure 2 , which displays the effectiveness of nicotine replacement therapy (NRT) for smoking cessation by using a patch (Stead et al., 2008) . In medical research, effect is often measured by log odds ratios or by log risk ratioslog(RR). Note that this graph is clearly not symmetric but rather skewed to the right. It is this skewness that is indicative of publication selection. Researchers and reviewers tend to have a preference for 'positive' effects and those that are statistically significant. For example, Turner et al. (2008) document how small and insignificant results from the RCT of antidepressants are not published in professional journals but their results are, by law, reported in the FDA registry- Figure 1 . Those that are significantly positive are much likely to also be published (Turner et al., 2008) . Publication selection for statistically significant findings will incidentally truncate estimates to have the wrong sign or are too small by random sampling errors. Such truncation will skew the funnel graph towards the desired direction-see Figure 2 and the half-moons in Figure 1 .
Publication selection is more easily seen among smaller, more imprecise, studies (i.e., those at the bottom of the funnel graph). Now consider, the funnel graph of the price elasticity of prescribed drugs- Figure 3 .
It appears to be nearly the exact mirror image of the previous funnel plot of NRT ( Figure 2 ). This graph is also clearly skewed, but this time exhibiting a preference for significantly negative price elasticities. Such a preference for negative price effects is perfectly understandable, because the 'Law' of demand requires the quantity demanded of any good to fall as its price rises. Publication selection in favor of negative price elasticities has been observed in many other areas of economics research . Although these funnel graphs can be quite suggestive (Stanley and Doucouliagos, 2010) , any visual inspection will remain somewhat subjective. To avoid subjective or idiosyncratic interpretations of funnel graphs, statistical tests have been designed to test their symmetry and to test for the presence of an underlying genuine effect.
With publication selection, researchers who have small samples and low precision will be forced to search more intensely across model specifications, data, and econometric techniques until they find larger estimates. Otherwise, their results will not be statistically significant. In contrast, researchers with more precise estimates need not search quite so hard from the practically infinite model specifications to find statistical significance and will thereby be satisfied with smaller estimated effects. When publication selection is present, the reported effects are positively correlated with their standard errors.
The conventional method to identify and accommodate publication bias is the simple meta-regression model:
(1) (Egger et al., 1997; Stanley, 2008) . Where effect i is some estimated empirical effect, often an elasticity, and SE i is its standard error. Equation (1) is the meta-regression equivalent of a funnel graph (Stanley and Doucouliagos, 2010) .
The conventional t-test of H 0 : α=0 from MRA model (1) is a valid, if low power, test for the presence of publication bias (Egger et al, 1997; Stanley, 2008) . On the other hand, the t-test of H 0 : β=0 is a powerful test for the presence of an authentic empirical effect beyond publication selection (Stanley, 2005; Stanley, 2008) . These tests have been called the 'funnelasymmetry test' (FAT) and the 'precision-effect test' (PET), respectively, and can be used to confirm (or deny) objectively the subjective impression gleaned from a visual inspection of a funnel graph.
However, in practice, equation (1) is almost never estimated by OLS due to its obvious heteroskedasticity. 7 Rather, some weighted least squares (WLS) version of (1) is employed, which can be obtained by dividing equation (1) through by SE i .
Where t i is the t-value for each reported empirical effect (TOM is it worthwhile reminding people that effect/se=t??). Alternatively, WLS may be estimated from equation (1) if the squared errors are weighted by precision squared (i.e., 1/SE i 2 ). Simulations show that the funnel-asymmetry and precision-effect tests can provide valid methods to identify publication selection and to test for the presence of a genuine effect beyond publication selection bias (Stanley, 2008) . Of course, empirical research is likely to be much more complex than what can be captured by any single variable. No doubt, there are factors other than publication selection that affect reported results, and their omission can potentially bias these results. Implicit in our simple MRA model of publication selection is the assumption that there is a single underlying empirical effect that each study is estimating, though imperfectly. However, heterogeneity is routinely observed among reported economic estimates, and this area of research is no exception. Thus, we need to consider a more complex meta-regression model that accommodates heterogeneity as well as publication selection. In the next section, we explicitly address this issue by investigating any of a number of multivariate MRA models.
III. CAN HEALTH RESEARCH BE WINNER'S CURSED?
Meta-Analysis Data
Having illustrated the publication selection in our examples above, we now focus on a metaanalysis of health care income and price elasticites and whether there is evidence of a 'winner's curse' in the area of health research. Meta-analysis requires a comprehensive collection of all available estimates on some empirical phenomenon. Our search identified and cross-referenced published studies using Econlit, Medline, and Sociofile. From each study, we have extracted a set of relevant characteristics including: standard errors, journal impact factor, the year of publication, type of data, level of aggregation, econometric techniques used, and health system. Descriptive statistics for these variables are reported in Table 2 . All income elasticity estimates come from aggregate studies (national or regional), because it is at the aggregate level where the health care-luxury good conundrum exists. 
Testing the Winner's Curse Hypothesis
To test the winner's curse hypothesis (WCRP) in a multivariate context, we use a general-tospecific approach (Davidson et al., 1978) . That is, all coded variables are included in the WLS version of MRA model (1), and insignificant variables are removed one at a time. "The strength of general to specific modeling is that model construction proceeds from a very general model in a more structured, ordered (and statistically valid) fashion, and in this way avoids the worst of data mining" (Charemza and Deadman 1997, p. 78) . The results are presented in columns 1 and 5 of Table 3 . The remaining columns in Table 3 remove the other moderator variables from the income elasticity MRA to ensure our main findings are robust to the choice of moderator variables.
In all cases, the MRA coefficient on Impact is statistically significant (p<.01), unambiguously corroborating WCRP. Impact is positive and statistically significant in all MRA models for income elasticities and significantly negative for price elasticities of prescribed drugs, directions that one would expect a prori.
The MRA coefficient on Impact is quite large (0.265-0.352) for income elasticites, easily making important practical differences in the reported elasticities. For example, when this estimated winner's curse effect is applied to the highest-rated journal, reported income elasticities would be expected to increase by 0.66 to 0.88 from this selection alone. When the estimated WCRP is combined with the estimated publication bias from SE in Table 3 , their combined effect increases expected elasticity anywhere from 1.00 to 1.42, again for the highest-rated journal. Needless to say, observed publication bias and WCRP are large enough to make an absolute necessity (i.e., income elasticity=0) appear to be a luxury. Thus, these results indicate both the WCRP hypothesis and publication selection among reported health care income elasticities, regardless of which MRA model is employed.
The pattern of variation found among these estimated MRA coefficients of publication selection (SE) is also instructive. Publication selection bias is estimated to be the largest when no other moderator variables are included in equation (1) and Impact both decline as additional moderators are added to our MRA model (Table 3) .
Such a coherent pattern would be expected if the associated types of data (NHS and Public)
were differentially selected in an effort to report large income effects. 10
As a further check of the robustness of these central findings, we also estimate the general-to-specific MRA model (column 1 Table 3 ) in several additional ways. It is widely recognized that reported empirical estimates will be dependent on one another if multiple estimates are collected from a single study (Stanley and Jarrell, 1989; Stanley, 2001) . Table 4 accounts for possible intra-study dependence using a variety of plausible assumptions about its structure. For our purposes, the most important finding is that the size, sign and significance of both WCRP (Impact) and publication selection bias (SE) remain unchanged. 11 For convenience, column 1 Table 3 , which reports the general-to-specific WLS MRA, is also reported in column 1 Table 4 . Column 2 Table 4 calculates cluster-robust standard errors when the data are clustered by study. Column 3 treats our meta-data as uneven panels structured across studies and reported estimates within studies. REML (restricted maximum likelihood) allows for random study effects and can be considered a mixed-effect multilevel model. The only notable difference among any of the statistical results is that one ancillary moderator variable (Public) is not statistically significant when a multilevel structure is employed. In all cases, our central hypotheses concerning publication selection are all corroborated.
As an additional check on the robustness of this robust corroboration of WCRP among health care elasticities, we apply these same MRA methods to a second area of health economics-price elasticities of prescribed drugs. 12 Table 3 column 5 reports the general-tospecific MRA for prescription drug elasticities. Only Impact and SE are statistically significant. Their estimated MRA coefficients confirm both a publication bias for significantly negative price elasticity (t=-3.02; p<.01) and WCRP (t=-4.10; p<.001).
Interestingly, when corrected for these publication biases, no statistically significant price effect remains (t=-0.24; p>>.05). That is, there is insufficient evidence to conclude that price increases of prescription drugs will cause any decrease in their use once both of these types of publication selection are accommodated. Likewise, when we include the other moderator variables and/or allow of intra-study dependence (Table 5) , both our central hypotheses about publication selection are robustly corroborated. 13 
Evidence from elasticity estimates
Ultimately, it is not the presence or absence of the winner's curse or publication bias that truly matters. Rather, it is the actual magnitude of health care income elasticity or the price elasticity of prescription that will have long-term consequences on the future of health care policy. When publication selection bias is corrected and/or WCRP is accommodated, reported estimates of income elasticity strongly reject the notion that the elasticity of health care is greater than one and that health care is a luxury. Taking the simplest MRA model, column 3 of Table 1 , the overall size of income elasticity corrected for publication selection is, in fact, not different than zero (β =-.0006; t=-.11; p>>.05) and very much less than one (reject H 0 : β > 1; t=-198.1; p<.0001). Thus, our meta-analysis of health care income elasticities is consistent with health care being an absolute necessity, but a not luxury.
Similarly, the corrected estimate of the price elasticity for prescribed drugs is only -0.039 (Table 1) , indicating it is highly inelastic. Although this corrected elasticity is statistically significant, it is practically negligible. Such a small elasticity suggests that pharmaceutical companies could double their prices and suffer only a 4% decline in sales, earning them a 92% increase in their revenues. This finding is consistent with the idea that prescribed drugs, like health care in general, are a strong necessity, even at the aggregate level.
When we use a multivariate MRA that includes the impact factor and possibly other moderator variables, some judgment is required to identify the best estimate of these health care related elasticities. That is, we must choose the best or most appropriate values for the other independent variables. As the winner's curse reflects a form of publication bias, the best estimate of income elasticity that minimizes this bias assumes that SE=0 and Impact=0.
When we impute the elasticities using these values in the multiple MRAs of the price elasticity of prescribed drugs, no statistically or practically significant price effect remains, regardless of our choice of the other moderating variables.
Applying this approach to estimate the income elasticity of health care we find that it is not statistically different from zero either ( βˆ=.001; t=.11; accept H 0 : β = 0), column 4 Table 3 . Adding the proportion of the sample that comes from a National Health Service (NHS) type system complicates but does not change this overall assessment. If we assume that everyone is covered by an NHS type system, we get the same results. However, if NHS=0 (i.e., no one is funded by the NHS), the estimate of income elasticity increases to 0.48 but is still much less than one (reject H 0 : β > 1; t=-4.33; p<.001). Note that the MRA coefficient on NHS is negative and statistically significant, as one would expect. As a greater proportion of the sample is covered by an NHS type system, health care expenditures would be expected to be less sensitive to income changes because of centralized price setting.
Regardless of which MRA model we use in Table 3 or 4, reasonable choices of the values on the other moderating variables return the prediction that health care is a necessity. Once allowance is made for publication selection, the notion that health care is a necessity is robustly corroborated by our MRA.
IV. CONCLUSION
This paper reports evidence consistent with the hypothesis of a winner's curse and publication selection bias in health care research on income and price elasticities. The winner's curse hypothesis claims that "the more extreme, spectacular results" are those preferentially selected for publication (Young et al., 2008) . This hypothesis is directly related to the long recognized and widely accepted problem of publication selection. If health research were to contain a winner's curse, we would expect to find that larger and more statistically significant findings are reported by higher impact journals. Our meta-analysis of health economics research on aggregate income and pharmaceutical price elasticites exhibits precisely this pattern; thus, indicating WCRP. Our meta-regression analysis identifies a clear and robust pattern in published health research. Higher impact journals report larger income elasticities.
Once allowance is made for publication selection bias and/or WCRP, the research record clearly rejects the idea that health care has an income elasticity greater than one and therefore that it is a 'luxury' good, in any sense of this term. All the corrected estimates of the income elasticity of health care are less than one but often not statistically different than zero, implying that health care is, if anything an absolute necessity. As show, when an area of research contains contested theories, selection biases are minimised. In contrast, when there is a widely accepted view (e.g., that prescribed drugs are price sensitive or that health care is an aggregate luxury good), reported results tend to confirm the consensus view, leading to large selection bias unless corrected by MRA.
We do not wish to claim that the winner's curse and publication selection bias are the only explanation of the widely reported evidence that health care is a luxury at the aggregate level. No doubt there are other potential explanations for the patterns that we find among reported price and income elasticities; certainly in the case of the income elasticity similar data have been used in multiple studies for example. Moreover, we did not and cannot entirely control for biases associated with spurious regressions, endogeneity, or omitting price and technology variables in the income equations. Thus, it is possible that what we identify as publication selection bias or the winner's curse may also be explained by a systematic selection of any number of these or other biases. However, if there is systematic selection of given estimate levels, as our MRA finds, then WCRP and publication selection remain a valid, if not unique, explanation. After all, such preferential selection of random errors and biases is the very definition of WCRP and publication selection bias.
If our meta-analysis is accepted then it clearly shows that the income elasticity of aggregate health care is not statistically greater than one, and that there is practically no reduction in the consumption of prescribed drugs due to increases in prices. Thus policy inferences built around the notion that health care is a luxury are wrong not only because they misuse a microeconomic concept in a macroeconomic setting, but also because the published research record, when corrected for publication bias, is not consistent with the notion that aggregate health care is a luxury. While the shifting of copayments on to patients through demand-risk sharing may do little to combat moral hazard in consumption or rising health care expenditure generally. ; where HE represents health expenditures and I represents income. 2 In economics, the 'winner's curse' is the phenomenon where the winning bidder systematically pays an inflated price, or receives a lower than expected profit, in common value auctions (Thaler, 1988) . 3 Over 90% of submitted research manuscripts are rejected by the top medical and economic journals 4 Ioannidis (2005) found that nearly a third of the most highly cited medical research studies (those with more than 1,000 citations) are contradicted by or found to have stronger effects than subsequent research published within a few years. 5 It is widely recognized that researchers have strong preferences for statistically significant results, whether these researchers are authors, reviewers or editors. Such a publication selection preference can be justified on the grounds that statistical significance is required if the findings are to be notable; that is, different from background noise. However, such generic publication selection need not be correlated with journal impact factor. 6 Details about how these estimates were collected from the research literature are given in Section III below. 7 SE i is an estimate of the standard deviation of the reported effect, which usually varies greatly from one econometric estimate to the next. 8 However, we find clear evidence of publication bias among the 50 RCTs of antidepressants that are published (t=5.47; p< .001)-also see (Turner et al., 2008; Moreno et al., 2009b) . 9 The conventional Q-test for heterogeneity is significant at any level (χ 2 (163) =19,272). 10 If researchers select, in part, across these important data and model dimensions to find the desired statistically significant or elastic estimate, it would explain the success of the simple MRA models in detecting and modeling this area of research. 11 The same is true if one uses these same estimation techniques as reported in Table 4 on the simpler MRA model that accounts for only Impact and publication selection. 12 We investigate these two areas of health economics research because they are the only two with meta-analyses that include the necessary information on both the SE and the impact factor.
